Turnstone Biologics Corp Common Stock
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -500 | -509 | -661 | -700 |
EBITDA | -21,557 | -20,182 | -17,197 | -18,230 |
EBIT | -22,057 | -20,691 | -17,858 | -18,930 |
Net Income | -21,304 | -19,629 | -16,450 | -17,319 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -16,122 | -17,604 | -15,504 | -19,046 |
Cash | 17,517 | 14,433 | 17,798 | 38,776 |
Basic Shares | 23,037 | 23,011 | 11,562 | 17,397 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|
Revenue | $19,306 | $73,300 | $101,293 |
Gross Profit | 16,506 | 71,100 | 99,281 |
EBITDA | -56,234 | -27,725 | 34,383 |
EBIT | -59,034 | -29,925 | 32,371 |
Net Income | -55,200 | -30,834 | 33,269 |
Net Change In Cash | 19,306 | 73,300 | 101,293 |
Free Cash Flow | -67,401 | -76,232 | -49,035 |
Cash | 17,798 | 34,731 | 123,381 |
Basic Shares | 11,562 | 22,188 | 22,188 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-06-30 | -$0.92 |
2024-03-31 | -$0.85 |
2023-12-31 | -$0.73 |
2023-09-30 | -$1 |
